UBS Group’s Intelligent Bio Solutions INBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.24K | Sell |
372
-3,682
| -91% | -$25.4K | ﹤0.01% | 9575 |
|
|
2025
Q4 | $38.6K | Buy |
+4,054
| New | +$33K | ﹤0.01% | 7361 |
|
|
2025
Q3 | – | Sell |
-30
| Closed | -$516 | – | 10587 |
|
|
2025
Q2 | $516 | Sell |
30
-87
| -74% | -$1.25K | ﹤0.01% | 9807 |
|
|
2025
Q1 | $1.69K | Sell |
117
-173
| -60% | -$3.23K | ﹤0.01% | 9464 |
|
|
2024
Q4 | $4.06K | Buy |
290
+135
| +87% | +$2.06K | ﹤0.01% | 8793 |
|
|
2024
Q3 | $2.68K | Sell |
155
-677
| -81% | -$10.6K | ﹤0.01% | 8389 |
|
|
2024
Q2 | $16K | Buy |
832
+797
| +2,277% | +$20.4K | ﹤0.01% | 7451 |
|
|
2024
Q1 | $1.47K | Buy |
+35
| New | +$1.45K | ﹤0.01% | 8125 |
|
|
2023
Q2 | – | Sell |
-5
| Closed | -$1.78K | – | 9237 |
|
|
2023
Q1 | $1.78K | Buy |
5
+1
| +25% | +$918 | ﹤0.01% | 8648 |
|
|
2022
Q4 | $2.15K | Buy |
+4
| New | +$3.84K | ﹤0.01% | 9726 |
|
|
2022
Q3 | – | Sell |
-5
| Closed | -$7.58K | – | 10611 |
|
|
2022
Q2 | $8K | Hold |
5
| – | – | ﹤0.01% | 8313 |
|
|
2022
Q1 | $9K | Buy |
5
+1
| +25% | +$2.3K | ﹤0.01% | 8550 |
|
|
2021
Q4 | $13K | Buy |
4
+1
| +33% | +$4.59K | ﹤0.01% | 8454 |
|
|
2021
Q3 | $16K | Buy |
+3
| New | +$23K | ﹤0.01% | 7418 |
|
|
2021
Q2 | – | Sell |
-1
| Closed | -$9K | – | 9572 |
|
|
2021
Q1 | $9K | Buy |
+1
| New | +$17.2K | ﹤0.01% | 8005 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 7624 |
|
Other funds holding INBS
AC
VCM
VFT
TRCT
CW